| May 14 2025 |
This Week in 340B: May 6 – 12, 2025 |
McDermott Will & Emery |
| May 14 2025 |
FAQ: Employee Stock Ownership Plans (“ESOPs”) in the Cannabis Industry |
Blank Rome LLP |
| May 14 2025 |
Have You Done Your Part to Comply with Part 2 Changes? |
Katten |
| May 14 2025 |
Pennsylvania PUC Reviews Data Center Impacts Amid New Energy Plan |
Polsinelli PC |
| May 14 2025 |
NC Legislature Considers Comprehensive Hemp Regulation: What Businesses Need to Know |
Ward and Smith, P.A. |
| May 12 2025 |
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program |
Mintz |
| May 12 2025 |
European Commission Previews New Round of Countermeasures Against the United States |
Squire Patton Boggs (US) LLP |
| May 9 2025 |
Minnesota Employment Legislative Update 2025, Part II: It’s Déjà Vu—Lengthy Omnibus Bills, Buried Employment Law Changes |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| May 9 2025 |
Onshoring Pharma Ops: Reading Recent EO and Policy Tea Leaves |
Sheppard, Mullin, Richter & Hampton LLP |
| May 9 2025 |
McDermott+ Check-Up: May 9, 2025 |
McDermott Will & Emery |
| May 8 2025 |
Is “Compromise” a Four-Letter Word? Alabama Legislature Passes Comprehensive Consumable Hemp Reform Bill |
Bradley Arant Boult Cummings LLP |
| May 8 2025 |
DEA Proposed Rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations |
Bradley Arant Boult Cummings LLP |
| May 8 2025 |
Litigation Minute: Tough to Swallow: Increased State Regulation of and Attention on Contaminants in Food |
K&L Gates LLP |
| May 8 2025 |
AI's Obstacles in Chemical Innovation: Polyani Paradox Impact |
Foley & Lardner LLP |
| May 8 2025 |
RAW Confusion? No Error Where Trial Court Declines to Clarify Agreed Jury Instruction |
McDermott Will & Emery |
| May 8 2025 |
No Supremacy Clause Preemption Where State Statute Doesn’t Conflict With Federal |
McDermott Will & Emery |
| May 7 2025 |
Unlocking the Future of Medicine: The Role of AI in Drug Discovery |
Foley & Lardner LLP |
| May 7 2025 |
Global Growth In GenAI Patenting Activity |
Foley & Lardner LLP |
| May 7 2025 |
The Rise of GenAI in Personalized Medicine and Beyond |
Foley & Lardner LLP |
| May 7 2025 |
This Week in 340B: April 29 – May 5, 2025 |
McDermott Will & Emery |
| May 7 2025 |
Bad Formatting Dooms Proposal and GAO Bid Protest |
Bradley Arant Boult Cummings LLP |
| May 6 2025 |
The Domino Effect: West Virginia’s State-Wide Dye Ban Leads Off FDA Action |
Sheppard, Mullin, Richter & Hampton LLP |
| May 6 2025 |
Navigating the Legal Soup: A New “Short-Form” Recipe for Prop 65 Warnings on Food and Beverages |
Sheppard, Mullin, Richter & Hampton LLP |
| May 6 2025 |
M-I-Crooked Letter, Crooked Letter-I-Crooked Letter, Crooked Letter-I-Humpback, Humpback-I: Checking in on Mississippi Cannabis |
Bradley Arant Boult Cummings LLP |
| May 6 2025 |
Pennsylvania Supreme Court Holds That CBD Products Can Be Reimbursable Medical Expenses Under Workers’ Compensation |
Norris McLaughlin P.A. |
| May 6 2025 |
The Potent Remedies Available Under the DTSA on Full Display in Insulet |
Squire Patton Boggs (US) LLP |
| May 5 2025 |
EPA Announces Release of Final Insecticide Strategy |
Bergeson & Campbell, P.C. |
| May 5 2025 |
White House Budget Documents Provide Additional Insights into the Trump Administration’s Priorities for HHS |
Mintz |
| May 5 2025 |
FDA Scores Win in Wages, but Industry Eyes Fifth Circuit Remand in Flavored Vape PMTA Denial Challenge |
Keller and Heckman LLP |
| May 5 2025 |
Re-evaluation of Acesulfame K (E 950) as Food Additive |
Keller and Heckman LLP |
| May 5 2025 |
Draft FDA Budget Proposes Cutting Funding, Shifting Food Inspections to States |
Keller and Heckman LLP |
| May 3 2025 |
China Releases Regulations on the Protection of New Plant Varieties |
Schwegman, Lundberg & Woessner, P.A. |
| May 2 2025 |
Constitutional Reform Initiative Regarding Pharmaceutical Sovereignty and Safety |
OLIVARES |
| May 2 2025 |
McDermott+ Check-Up: May 2, 2025 |
McDermott Will & Emery |
| May 2 2025 |
Navigating the Regulatory Landscape for Private Label Alcohol |
McDermott Will & Emery |
